Tech Company Financing Transactions
Mirador Therapeutics Funding Round
Mirador Therapeutics, based in San Diego, secured $400 million from Arch Venture Partners, Alexandria Venture Investments and Blue Owl Capital.
Transaction Overview
Company Name
Announced On
3/25/2024
Transaction Type
Venture Equity
Amount
$400,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to advance its programs.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
3115 Merryfield Row 210
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Undisclosed
Website
Email Address
Overview
Improve the lives of people with immune-mediated diseases through innovative precision medicine. Develop transformational precision therapies for immune-mediated diseases by leveraging cutting-edge biology, multi-modal data, and advanced analytics.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mark McKenna
Chief Financial Officer
Vika Brough
Chief Medical Officer
Allison Luo
Chief Scientific Officer
Olivier Laurent
VP - Bus. Development
William Sandborn
VP - Bus. Development
Jordan Zwick
VP - General Counsel
Tim Andrews
VP - Human Resources
Nori Ebersole
Browse more venture capital transactions:
Prev: 3/25/2024: Foundational venture capital transaction
Next: 3/25/2024: Iron Sheepdog venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs